Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma

Patrizia Tempora, Silvia D’Amico, Paula Gragera, Verena Damiani, Kamila Krol, Valentina Scaldaferri, Kirti Pandey, Shanzou Chung, Valeria Lucarini, Ezio Giorda, Marco Scarsella, Gabriele Volpe, Marco Pezzullo, Cristiano De Stefanis, Valentina D’Oria, Lorenzo De Angelis, Roberto Giovannoni, Maria Antonietta De Ioris, Ombretta Melaiu, Anthony W. Purcell, Franco Locatelli, Doriana Fruci

Open source

DOI: 10.1186/s13046-024-03180-y
Published: 2024-10-22
Container: Journal of Experimental & Clinical Cancer Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13046-024-03180-y,
  title = {Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma},
  author = {Patrizia Tempora and Silvia D’Amico and Paula Gragera and Verena Damiani and Kamila Krol and Valentina Scaldaferri and Kirti Pandey and Shanzou Chung and Valeria Lucarini and Ezio Giorda and Marco Scarsella and Gabriele Volpe and Marco Pezzullo and Cristiano De Stefanis and Valentina D’Oria and Lorenzo De Angelis and Roberto Giovannoni and Maria Antonietta De Ioris and Ombretta Melaiu and Anthony W. Purcell and Franco Locatelli and Doriana Fruci},
  year = {2024},
  journal = {Journal of Experimental \&amp; Clinical Cancer Research},
  doi = {10.1186/s13046-024-03180-y},
  url = {https://doi.org/10.1186/s13046-024-03180-y}
}

RIS

TY  - JOUR
TI  - Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma
AU  - Patrizia Tempora
AU  - Silvia D’Amico
AU  - Paula Gragera
AU  - Verena Damiani
AU  - Kamila Krol
AU  - Valentina Scaldaferri
AU  - Kirti Pandey
AU  - Shanzou Chung
AU  - Valeria Lucarini
AU  - Ezio Giorda
AU  - Marco Scarsella
AU  - Gabriele Volpe
AU  - Marco Pezzullo
AU  - Cristiano De Stefanis
AU  - Valentina D’Oria
AU  - Lorenzo De Angelis
AU  - Roberto Giovannoni
AU  - Maria Antonietta De Ioris
AU  - Ombretta Melaiu
AU  - Anthony W. Purcell
AU  - Franco Locatelli
AU  - Doriana Fruci
PY  - 2024
JO  - Journal of Experimental &amp; Clinical Cancer Research
DO  - 10.1186/s13046-024-03180-y
UR  - https://doi.org/10.1186/s13046-024-03180-y
ER  -

APA

Tempora, P., D’Amico, S., Gragera, P., Damiani, V., Krol, K., Scaldaferri, V., Pandey, K., Chung, S., Lucarini, V., Giorda, E., Scarsella, M., Volpe, G., Pezzullo, M., Stefanis, C. D., D’Oria, V., Angelis, L. D., Giovannoni, R., Ioris, M. A. D., Melaiu, O., Purcell, A. W., Locatelli, F., & Fruci, D. (2024). Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-024-03180-y

Source records

crossref · retrieved 2026-09-26T09:42:54.047Z